Hello -

I recently got an echocardiogram that showed a mildly dilated Aortic root of 4.5 cm and prox ascending aorta of 4.0. The valves were fine with no regurgitation. It didn’t mention anything about bicuspid valve etc but rather said it was grossly normal.

Interestingly, I had a CAC scan about 8 months ago that stated “Normal caliber ascending aorta” and nothing about the root.

The person who performed the echo was a student. And the report said “Technically Fair Study Images”.

I have been referred to cardiology and am awaiting their call.

My question is what is the likelihood that the echo measurement was not actually accurate and my aorta and root are actually of a more normal size? Kind of freaking out here until I can see a cardiologist.

Edit: Adding that my BP is completely normal at 115/75 and I have no family history of this sort of thing or any known connective tissue disease.

My father, 73M, has been diagnosed with an 8 cm aortic aneurysm and the doctor has said it needs to be done in 2 stages because also has the thoracic one that he needs to remove. I am scared that the aortic aneurysm will rupture before the surgery. He has changed his lifestyle and his blood pressure is good right now. Should I tell the doctor to do the 8cm first? I don’t know. I feel there’s more he can do.

2 years post-op here. Before surgery I started using AI to help me actually understand my own chart, my diagnosis, how to explain it to my children, my follow-up questions ... stuff I used to just nod along to in appointments.

It changed a lot for me, not just what I knew, but how calm I felt in knowing things.

Curious if this resonates with anyone else? did any of you try using AI tools during prep or recovery to make sense of your own care? Did it help, or did it just add noise? Genuinely trying to figure out if this is a "me" thing or a real pattern

Hello,

So I recently got a CT scan to rule out some former smoker stuff for my lungs and good news is the lungs are decent. i did however get some findings on both coronary artery atherosclerosis and ascending aorta dilation of 4.5. Here are the findings:

"Aorta: Dilation ascending aorta to 4.5 cm, with gradual taperingacross aortic arch. Descending aorta 3.7 cm diameter.

Mediastinum: Slight GE junction hiatus herniation into inferiormediastinum.

Moderately enlarged heart, enlargement especially of left ventricle. No pericardial effusion.

Coronary calcifications: Marked, LAD, left circumflex, right.

Other extrapulmonary findings:

Several coarse atherosclerotic calcifications of visualized upper

abdomen.

33 mm exophytic upper pole right renal cyst.

Impresssion:

Moderate to severe coronary artery atherosclerosis

Ascending thorasic aorta aneurysm up to 4.5cm"

Im 59, 6ft tall and 215 lbs. Should i be more worried about the Aorta or the heart disease?. They both have freaked me out.

I have met with cardiologistand have increased my statins to 40mg and now have cholesterol under control to about 80. My echo stress test claimed i have a functional heart of a 40 year old. and put the aorta at 4.0 CM ( which is a pretty decent deviation from what the CT scan showed. also stated "LV EF is 60% , assesed by visual estimation"

I also have sinus bradycardia which i am pretty sure i knew my heart rate was low.

Should i just check once a year and get on with it ? or are these things somethign to truly stress about?

Thank you.

Specific inflammatory and infectious etiologies of aortic dilation (AD) have demonstrated reversal or significant regression when the underlying disease is aggressively treated, distinct from mere stabilization.

Here are the specific diseases where reversal of aortic dilation has been documented via targeted medical therapy:

1. IgG4-Related Disease (IgG4-RD)

This is a prime example of reversible AD driven by lymphoplasmacytic infiltration and fibrosis.

• Evidence of Reversal: Case series and cohort studies document that high-dose corticosteroids (e.g., prednisone) and rituximab can lead to a >50% reduction in aortic wall thickness and, crucially, a reduction in luminal diameter in aneurysmal segments if treated before extensive scarring occurs.
• Mechanism: The dilation is largely due to active inflammation and edema within the adventitia and media. Resolving the IgG4-driven plasma cell infiltration allows the aortic wall to "shrink" back toward normal dimensions.
• Clinical Note: Regression of the periaortic soft tissue mass is common, but luminal diameter reduction is specifically noted in early-stage aneurysmal dilation where the structural scaffold (elastin) is not yet fully destroyed.

2. Syphilitic Aortitis (Tertiary Syphilis)

Caused by Treponema pallidum obliterating the vasa vasorum, leading to medial necrosis and dilation.

• Evidence of Reversal: While established "tree-barking" scarring is permanent, early syphilitic aortitis with associated dilation can see halting of progression and partial regression of the inflammatory component upon treatment with penicillin.
• Mechanism: Eradication of the spirochete stops the immune-mediated destruction of the media. In cases where dilation was exacerbated by active inflammatory edema rather than pure tissue loss, antibiotic therapy has resulted in reduced aortic dimensions.
• Distinction: This is a curative treatment of the cause; without it, dilation inevitably progresses to rupture.

3. Giant Cell Arteritis (GCA) and Takayasu Arteritis

Large-vessel vasculitides where granulomatous inflammation weakens the aortic wall.

• Evidence of Reversal: Aggressive immunosuppression with corticosteroids, tocilizumab (IL-6 inhibitor), or methotrexate has been shown to reverse aortic wall thickening and, in some documented cases, reduce the diameter of early aneurysmal dilations.
• Mechanism: The dilation is often a combination of inflammatory infiltration and vasospasm/edema. Resolving the granulomatous inflammation reduces wall stress and allows elastic recoil.
• Critical Window: Reversal is most documented when therapy is initiated during the active inflammatory phase (high ESR/CRP, PET-avid aorta) before irreversible elastin fragmentation occurs.

4. Sarcoidosis (Cardiac/Aortic Sarcoid)

Granulomatous infiltration of the aortic wall can mimic aneurysmal dilation.

• Evidence of Reversal: Case reports describe the resolution of aortic masses and reduction in aortic caliber following treatment with corticosteroids and TNF-α inhibitors (e.g., infliximab, adalimumab).
• Mechanism: Similar to IgG4-RD, the "dilation" is often partly due to the bulk of the granulomatous inflammation itself. Dissolving the granulomas reduces the effective diameter and wall stress.

5. Ankylosing Spondylitis (AS) and IL-17/IL-23 Axis Disorders

AS is associated with aortitis, particularly at the root.

• Evidence of Reversal: While less commonly cited as "aneurysm reversal" compared to IgG4-RD, the use of IL-17 inhibitors (e.g., secukinumab, ixekizumab) and TNF-α inhibitors has been shown to halt aortic root dilation and reduce aortic wall inflammation (quantified by MRI/PET).
• Mechanism: Blocking the IL-17 pathway directly addresses the enthesitis and aortitis specific to spondyloarthropathies. By suppressing the cytokine storm driving the medial destruction, the viscoelastic properties of the aorta can recover, potentially leading to dimensional regression in early active disease.
• Relevance: This supports that targeting the specific cytokine (IL-17 vs. TNF) driving the inflammation in specific genetic backgrounds (e.g., HLA-B27) is superior to generic blood pressure control.

6. Biomechanical/Inflammatory Models (AT2R Activation)

While not a "disease" per se, this mechanistic insight supports ARB BP control.

• Evidence: Studies show that AT2R activation (in conjunction with AT1R blockade) can reverse aortic dilation induced by biomechanical stress by actively resolving adventitial inflammation and reducing MMP-9 expression.
• Implication: This confirms that AD is not just a passive stretch but an active inflammatory process that can be biologically reversed if the signaling pathways (like Ang II Type 2 receptor) are correctly modulated.

https://preview.redd.it/2xvpjundivah1.png?width=1079&format=png&auto=webp&s=9883426da7f52128771b7b46a334988034137dd2

The clinical lesson is that phenotyping the inflammation (IgG4, Granulomatous, IL-17 driven, or TGF-β driven) allows for targeted therapy that can reverse the dilation, whereas treating all AD as "degenerative" leads only to surveillance and eventual surgery.

The dogma that "aneurysms cannot shrink" is being dismantled by evidence showing that active remodeling (driven by inflammation, proteolysis, or metabolic deficiency) can be reversed if the specific driver is targeted.

Here is the expanded list of diseases and conditions where Aortic Dilation (AD) has been documented to reverse or significantly regress via targeted medical therapy:

1. Vitamin D Deficiency-Associated Aortopathy

You correctly identified this. Vitamin D deficiency is not just a risk factor; it is a direct driver of aortic inflammation and dilation via the C3a complement pathway.

• Evidence of Reversal: Recent murine studies (2024–2026) demonstrate that Vitamin D3 supplementation (specifically restoring levels >75 nmol/L) in deficient models leads to a significant reduction in aortic diameter and prevents rupture.
• Mechanism: Deficiency upregulates Complement Component C3a, driving leukocyte infiltration and elastin fragmentation. Calcitriol (active Vitamin D) suppresses C3a production in vascular smooth muscle cells (VSMCs), resolving the inflammation and allowing the aortic wall to recoil.
• Clinical Implication: In patients with documented deficiency and active dilation, high-dose supplementation is not just supportive but potentially regressive.

2. Matrix Metalloproteinase (MMP)-Driven Dilation (e.g., Marfan Syndrome)

While genetic, the dilation phase is driven by excessive MMP activity (specifically MMP-2 and MMP-9) which degrades elastin.

• Evidence of Reversal: Long-term treatment with Doxycycline (a potent MMP inhibitor) has been shown in Marfan mouse models to reverse aortic dilation and restore elastic fiber organization. In human trials post-EVAR (endovascular repair), doxycycline reduced maximum aortic diameter by ~13% compared to placebo in endoleak-free patients.
• Mechanism: Doxycycline directly inhibits MMP catalytic activity and downregulates MMP gene expression, halting elastolysis and allowing the wall to stabilize and potentially shrink back from the dilated state.
• Distinction: This targets the enzymatic destruction rather than just the blood pressure.

3. Hypercholesterolemia / Statin-Responsive Aortopathy

Chronic lipid infiltration drives inflammatory remodeling in the aortic wall, distinct from simple atherosclerosis.

• Evidence of Reversal: Meta-analyses (2023–2024) confirm that statin therapy (e.g., atorvastatin) significantly reduces aneurysm diameter size (mean reduction ~0.30 mm) and growth rate. In vitro, statins reverse TGF-β1-induced fibrosis in VSMCs.
• Mechanism: Statins exhibit pleiotropic effects: they inhibit Rho-kinase pathways, reduce oxidative stress, and suppress MMP secretion. This shifts the balance from degradation to repair, allowing for dimensional regression in active, lipid-driven inflammation.

4. Omega-3 Fatty Acid Deficiency / Inflammatory Aortopathy

Dietary imbalances can drive the inflammatory cascade responsible for dilation.

• Evidence of Reversal: Systematic reviews indicate that Omega-3 supplementation significantly reduces aortic diameter in animal models and decreases pulse wave velocity (stiffness) in humans.
• Mechanism: Omega-3s (EPA/DHA) compete with arachidonic acid, reducing the production of pro-inflammatory eicosanoids and resolving the chronic low-grade inflammation that sustains the dilated state.

5. Active Infectious Aortitis (Beyond Syphilis)

While Syphilis is the classic example, other infections cause reversible dilation if treated before necrosis is complete.

• Salmonella & Staphylococcal Aortitis: Early aggressive antibiotic therapy (e.g., fluoroquinolones for Salmonella, anti-staphylococcal agents) can resolve the inflammatory mass and reduce the functional diameter if the structural integrity hasn't fully collapsed.
• Mechanism: Eradication of the pathogen halts the release of bacterial proteases and the host immune response, allowing the edematous, inflamed wall to resolve.

6. Signaling Pathway-Driven Remodeling (Experimental but Promising)

Research into specific signaling inhibitors shows that even established aneurysms can regress if the "growth signal" is blocked.

• JNK and NF-κB Inhibition: Experimental models show that inhibiting these specific inflammatory signaling pathways results in regression of established aneurysms.
• Rosiglitazone (PPAR-γ agonist): Used in diabetes, this drug inhibits JNK/MAPK pathways and has been shown to reduce aneurysm formation and promote regression in experimental settings by modulating the inflammatory phenotype of macrophages.

https://preview.redd.it/qv7gog2rivah1.png?width=1083&format=png&auto=webp&s=d8bc5e9b2f1fb32d6d142cd2cc8c98548c77dad0

The failure to reverse AD often stems from treating the dimension (watchful waiting) rather than the driver (inflammation, proteolysis, deficiency). Identifying whether a patient's dilation is driven by low Vitamin D, high MMPs, lipid inflammation, or cytokine storms (IL-17, TGF-β) allows for the specific medical therapy that can induce regression, rendering surgery unnecessary in many early-to-moderate cases.

Conclusive Statement: Aortic Dilation is a Treatable, Often Reversible Condition

The original presumption that aortic dilation (AD) is an irreversible, passive structural failure requiring only surveillance until surgery is medically obsolete and potentially harmful. Current evidence confirms that AD is an active, dynamic disease process driven by specific molecular, inflammatory, and metabolic mechanisms that can be halted, stabilized, and in many cases, reversed.

The Hope is Real and Evidence-Based:

1. Reversal is Documented: AD has been shown to regress in multiple conditions when the underlying driver is targeted:
   • Inflammatory Aortitis (IgG4-RD, Giant Cell Arteritis, Sarcoidosis): Immunosuppression (steroids, rituximab, IL-6/IL-17 inhibitors) resolves the inflammatory mass and reduces aortic diameter.
   • Infectious Aortitis (Syphilis, Salmonella): Antibiotic eradication of the pathogen halts destruction and allows healing.
   • Genetic/Signaling Disorders (Marfan, Loeys-Dietz): Supramaximal ARB dosing and MMP inhibition (doxycycline) have demonstrated aortic root regression by blocking TGF-β and proteolytic degradation.
   • Metabolic/Deficiency States: Vitamin D3 supplementation reverses dilation in deficient models by suppressing the C3a complement pathway; high-dose statins reduce aneurysm diameter by inhibiting Rho-kinase and MMPs; Omega-3 fatty acids reduce diameter by resolving inflammatory eicosanoids.
2. The Mechanism is Active Remodeling: AD is not merely "stretching"; it is a state of chronic inflammation, proteolysis (elastin destruction), and failed repair. When these pathways (TGF-β, MMPs, IL-17, C3a, NF-κB) are pharmacologically blocked, the aortic wall can recover its structural integrity and dimensions.
3. The Clinical Imperative: Denying this hope by labeling AD as "irreversible" leads to therapeutic nihilism—a failure to test for underlying causes (genetic, inflammatory, metabolic) and a failure to prescribe targeted, disease-modifying therapies. The standard of care must shift from "watchful waiting" to active molecular phenotyping and aggressive medical management.

Final Message to the Naive Reader: You are not powerless against aortic dilation. It is not a guaranteed sentence to surgery. By identifying and treating the root cause—whether it is a genetic signaling error, a hidden autoimmune fire, a silent infection, or a simple vitamin deficiency—healing and reversal are possible. Demand a workup for these underlying diseases. Ask about supramaximal ARBs, doxycycline, vitamin D optimization, and anti-inflammatory biologics. The science has moved forward; ensure your care does too.

And another 'final' message, do not come onto this thread to spread your hate or unhappiness. If you disagree, that's fine, continue to 'watch and wait'; I don't want to hear it, go start your own thread. This thread is for information only.

Hey y’all as this community has helped me a ton in the past few months I thought I’d jump on and share my progressing success story.

I found out about my 5.1cm aortic aneurysm in April after having no idea it was growing due to my bicuspid valve. Obviously a very scary discovery and despite my cardiologists odd advice to stay active and continue low level rock climbing, I kept it very chill to avoid any issues

Fast forward to today 7/1 and I’m very much on the mend from my root sparing surgery on 6/29 with Dr Desai at UPenn. I couldn’t say anything better about his expertise and how incredible the team has been.

The first few days were rough as I was fairly awake for the breathing tube to come out but after that and some of the chest tubes come out it is truly so much easier.

Again I cannot recommend Dr Desai enough and his confidence but my wife and I at ease throughout the whole process. We were referred by my wife’s family (medical careers on both sides) as he is one of the countries if not worlds leading surgeons in halve sparing surgeries.

I’m probably going home Friday and in disbelief of how manageable they have made this surgery.

I‘m 34f, 5’6 and have a 4cm aortic root right now. I understand that it can remain stable or grow and I’m supposed to get annual scans to monitor.

i guess I just don‘t really understand like…how likely is it that I’ll need heart surgery at some point? How many years away would that probably be? It seems like I have (hopefully) a long time left for it to potentially grow so I’m wondering if surgery is inevitable or if it can really stay stable for the rest of my life. What is average or expected?

Hii anyone diagnos with unicupsid valve
We are very confused with mean gradient last year it was 22mmhg
This year 30mmhg on echo
Everything us stable like leakage and asending arota 4.even valve area is 1.6cm2
Anyone unicupsid valve please ahre their ecperince please because this valve is rare and can anyone tell how long after diagnos u been moderate and stable
We are afriad it gona severe next year please help us

I am curious, has anyone been approved for elective plastic surgery while being monitored for aorta (4.5 cm) and BAV? I am inclined to think not.

I am a 48m, had a full body mri done which determined I had a dilated upper aorta at 4.2 cm.
Have since seen a cardiologist who did further testing, increasing my blood pressure meds.

He mentioned no more weight lifting, running is basically gotta be limited as he said if you can’t hold a normal conversation while doing it, then don’t do it. And no exercises which can cause you to hold your breath etc

Going from exercising almost daily to just about nothing is mentally destroying me. Anyone else exercise at all and find anything that seems to keep you fit yet not strain the aneurysm?

My dad (66) has an abdominal aortic aneurysm repair scheduled and as expected I am terrified. I am really bad with hospitals so what would I expect his condition and recovery to be like? Any complications I should be wary of or is it best to try not to think about it?? The size of his aneurysm is 5.6cm and his stress test came back good and so did his ecg and he’s been monitored for this for 2 years as he’s got very high blood pressure so this surgery isn’t much of a surprise but still very nerve wracking.

Hes never had surgery before and I’m worried about the pain he will be in. If anyone has any support or advice it will be greatly appreciated!

I am an EMT-B who does additional EMS for Wildnerness and sporting events as a side job.

I had a patient (60s M) yesterday during a long distance biking event who apparently had an aortic aneurysm.

20 miles into the 80 mile ride of the day (day 5 of the 7 day event), patient described a sudden headache and the feeling of a sudden increase in blood pressure, followed by dizziness.

Patient stated the headache and feeling of higher blood pressure dissipated quickly, but the dizziness remained.

Patient flagged down a staff member who gets the patient and his bike into the van, and starts driving towards me. Staff member calls me to let me know, and asks to give him aspirin. I say no.

At this point, patient begins experiencing numbness and weakness in his left leg, along with the continued dizziness.

Patient arives at my location within maybe 5 minutes.

I start doing my thing. His vitals are fairly stable with the only standouts being a slightly high BP with a systolic in the 150s (patient has a hx of hypertension and took his meds at his normal daily time), and a slightly low O2 satting at 93.

He is alert and oriented the entire time. He has the above-mentioned Hx of hypertension, and also had a stent placed a year earlier.

Mild dizziness, and increasing leg numbness and weakness remain the only symptoms. Absolutely no pain, either in the leg, or anywhere else.

Second set of vitals show a drop in O2, now at 85. I give him 4lpm and he goes back up.

Patient shows no signs of a stroke, and has a pedal pulse in the affected leg.

At this point, ALS arrives on scene and he gets transported to a local hospital.

I was kind of guessing maybe DVT or something.

I find out later he was air transferred to a much larger facility a few hours away. Initially I was told for a clot in the leg.

Next day I am told he ended up getting open heart surgery for an aortic aneurysm overnight, and is now awake and speaking.

I understand at the EMT-B level there isnt much I can do for something like that besides get him to a higher level of care.

My questions are;

1. Should I have suspected an aortic aneurysm based on the symptoms? It was nowhere near the top of my list. Patient had no pain whatsoever. This is not what I would expect an aortic aneurysm to look like. I have seen several with very different, more classic symptoms.

2. I am glad I told the driver not to give him aspirin, but if the driver had done it without asking, is there a high likelihood his bleeding would have increased to an unsustainable level before he reached a hospital?

3. I was initially told he had a clot in the leg and that was why he was being airlifted to a larger facility. Is it possible somehow the aneurysm/dissection was secondary to a clot in the leg? Could a clot contribute to an aneurysm?

Or is it more likely I was misinformed and there was no clot at all and that was just a misunderstanding by the event staff who told me?